That would be great news and while we can only hope, pancreatic cancer was one of the 6 cancers CytoDyn filed expanded access IND for back in November. If he isn't one that has applied for leronlimab, I hope that CytoDyn proves itself in cancer before it is too late for him.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.